The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 218K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grey, S. T.
Right arrow Articles by Ferran, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grey, S. T.
Right arrow Articles by Ferran, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/1999/10/1135/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 8, October 18, 1999 1135-1146

A20 Inhibits Cytokine-induced Apoptosis and Nuclear Factor {kappa}B–dependent Gene Activation in Islets

Shane T. Greya, Maria B. Arveloa, Wendy Hasenkampb, Fritz H. Bacha, and Christiane Ferrana
a Immunobiology Research Center, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215
b Joslin Center for Diabetes, Boston, Massachusetts 02215

Correspondence to: Christiane Ferran, Immunobiology Research Center, Harvard Medical School, Beth Israel Deaconess Medical Center, 99 Brookline Ave., Boston, MA 02215. Tel:617-632-0840 Fax:617-632-0880 E-mail:cferran{at}caregroup.harvard.edu.

Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease resulting from apoptotic destruction of ß cells in the islets of Langerhans. Low expression of antioxidants and a predilection to produce nitric oxide (NO) have been shown to underscore ß cell apoptosis. With this perspective in mind, we questioned whether ß cells could mount an induced protective response to inflammation. Here we show that human and rat islets can be induced to rapidly express the antiapoptotic gene A20 after interleukin (IL)-1ß activation. Overexpression of A20 by means of adenovirus-mediated gene transfer protects islets from IL-1ß and interferon {gamma}–induced apoptosis. The cytoprotective effect of A20 against apoptosis correlates with and is dependent on the abrogation of cytokine-induced NO production. The inhibitory effect of A20 on cytokine-stimulated NO production is due to transcriptional blockade of inducible NO synthase (iNOS) induction; A20 inhibits the activation of the transcription factor nuclear factor {kappa}B at a level upstream of I{kappa}B{alpha} degradation. These data demonstrate a dual antiapoptotic and antiinflammatory function for A20 in ß cells. This qualifies A20 as part of the physiological cytoprotective response of islets. We propose that A20 may have therapeutic potential as a gene therapy candidate to achieve successful islet transplantation and the cure of IDDM.

Key Words: A20, ß cells, nuclear factor {kappa}B, nitric oxide, apoptosis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS